Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity.
Fiche publication
Date publication
juin 2017
Journal
Radiation oncology (London, England)
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERNIER-CHASTAGNER Valérie, Pr PEIFFERT Didier
Tous les auteurs :
Jolnerovski M, Salleron J, Beckendorf V, Peiffert D, Baumann AS, Bernier V, Huger S, Marchesi V, Chira C
Lien Pubmed
Résumé
To report grade ≥2 overall late rectal and urinary toxicities in patients (pts) with prostate cancer treated by intensity-modulated radiotherapy (IMRT) at 3 dose-levels. Identify predictors of radiation toxicity and report biochemical progression free survival (bPFS).
Mots clés
Intensity-modulated radiation therapy, Prognostic factors, Prostate cancer, Rectal and urinary toxicity
Référence
Radiat Oncol. 2017 Jun;12(1):99